Consonance Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Consonance Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,969,027	Closed	-$26M	–	30
2018 Q4	$26M	Sell	2,969,027 -2,860,851	-49%	-$36.4M	1.91%	15
2018 Q3	$97.9M	Sell	5,829,878 -1,133,878	-16%	-$24.5M	5.27%	6
2018 Q2	$146M	Buy	6,963,756 +760,400	+12%	+$14.1M	9.41%	1
2018 Q1	$99.8M	Sell	6,203,356 -1,180,110	-16%	-$23.4M	9.12%	2
2017 Q4	$140M	Sell	7,383,466 -1,325,665	-15%	-$24M	12.64%	1
2017 Q3	$123M	Buy	8,709,131 +6,688,548	+331%	+$60.5M	13.55%	1
2017 Q2	$15.1M	Buy	+2,020,583	New	+$13.2M	1.77%	13

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Consonance Capital Management's SPPI Position: Q1 2019 in Review

Consonance Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2019, closing a stake of 2,969,027 shares — an estimated $26M sold.

Consonance Capital Management first reported a position in SPPI in Q2 2017 and held it in 7 quarters. The position peaked at $146M in Q2 2018. 173 funds tracked by Wall St. Rank hold SPPI as of Q1 2019.

Consonance Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2019 after selling out during the quarter.
Consonance Capital Management sold 2,969,027 Spectrum Pharmaceuticals Inc shares in Q1 2019, an estimated $26M.
Consonance Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2017 and held it in 7 quarters.
Consonance Capital Management's Spectrum Pharmaceuticals Inc position peaked at $146M in Q2 2018.
173 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2019.

Based on Consonance Capital Management's 13F filing for Q1 2019, filed 15 May 2019.